These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25813683)

  • 1. [Rare tumors: the need for special centers].
    Massard C
    Bull Cancer; 2014 Feb; 101(2):115. PubMed ID: 25813683
    [No Abstract]   [Full Text] [Related]  

  • 2. Collaboration is key to treating uncommon cancers: scientists and patients champion research in these rare diseases.
    Printz C
    Cancer; 2010 Jun; 116(12):2847-9. PubMed ID: 20564387
    [No Abstract]   [Full Text] [Related]  

  • 3. [Care networks in oncology, an evidence for all?].
    Ray-Coquard I; Ducimetière F; Farsi F
    Bull Cancer; 2013; 100(7-8):650-4. PubMed ID: 24063023
    [No Abstract]   [Full Text] [Related]  

  • 4. Rare cancers: A network for better care.
    Sandrucci S; Gatta G
    Eur J Surg Oncol; 2019 Jan; 45(1):1-2. PubMed ID: 30041942
    [No Abstract]   [Full Text] [Related]  

  • 5. The promise and challenges of rare cancer research.
    Komatsubara KM; Carvajal RD
    Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
    [No Abstract]   [Full Text] [Related]  

  • 6. Rare cancers: a sea of opportunity.
    Boyd N; Dancey JE; Gilks CB; Huntsman DG
    Lancet Oncol; 2016 Feb; 17(2):e52-e61. PubMed ID: 26868354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France].
    Ray-Coquard I; Pautier P; Pujade-Lauraine E; Méeus P; Morice P; Treilleux I; Duvillard P; Alexandre J; Lhommé C; Selle F; Guastalla J
    Bull Cancer; 2010 Jan; 97(1):123-35. PubMed ID: 20007069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Challenges for clinical research on rare tumors in Europe].
    Blay JY
    Bull Acad Natl Med; 2013 Jan; 197(1):103-21; discussion 121-2. PubMed ID: 24672983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specialized teams or specialist networks for rare cancers?
    Sandrucci S; Gatta G; Trama A; Dei Tos AP; Casali PG
    Eur J Surg Oncol; 2015 Sep; 41(9):1115-7. PubMed ID: 25936223
    [No Abstract]   [Full Text] [Related]  

  • 10. Genome project aims to transform treatment of cancer and rare diseases.
    Godlee R
    BMJ; 2014 Aug; 349():g4972. PubMed ID: 25085691
    [No Abstract]   [Full Text] [Related]  

  • 11. Addressing challenges in the diagnosis and treatment of rare genetic diseases.
    Boycott KM; Ardigó D
    Nat Rev Drug Discov; 2018 Mar; 17(3):151-152. PubMed ID: 29242613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do we need randomised trials for rare cancers?
    Prasad V; Oseran A
    Eur J Cancer; 2015 Jul; 51(11):1355-7. PubMed ID: 25963018
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current views on rare diseases research and orphan drugs development].
    Jiang J; Li J; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):724-9. PubMed ID: 21845839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The founding of the European Cooperative Study Group on Pediatric Rare Tumors--EXPeRT.
    Ferrari A; Schneider DT; Bisogno G;
    Expert Rev Anticancer Ther; 2013 Jan; 13(1):1-3. PubMed ID: 23259419
    [No Abstract]   [Full Text] [Related]  

  • 15. [Centralized treatment of rare types of cancer].
    Schem BC
    Tidsskr Nor Laegeforen; 2002 Sep; 122(21):2088. PubMed ID: 12555641
    [No Abstract]   [Full Text] [Related]  

  • 16. Rare diseases: what do you need to know?
    Stewart S; Peers K
    Nurs Times; 2013 Nov 13-19; 109(45):12-4. PubMed ID: 24380183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of personalized medicine: cancer and rare diseases.
    Alves ITS; Condinho M; Custódio S; Pereira BF; Fernandes R; Gonçalves V; da Costa PJ; Lacerda R; Marques AR; Martins-Dias P; Nogueira GR; Neves AR; Pinho P; Rodrigues R; Rolo E; Silva J; Travessa A; Leite RP; Sousa A; Romão L
    Cell Oncol (Dordr); 2018 Jun; 41(3):335-341. PubMed ID: 29633150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rare diseases as models in clinical research--from genetics to better medical care ].
    Schmidtke J; Schmidt RE
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1475-6. PubMed ID: 18058147
    [No Abstract]   [Full Text] [Related]  

  • 19. development of a therapeutic approach to rare cancers in children: the Children's Oncology Group experience.
    Pashankar FD; Rodriguez-Galindo C; Pappo A
    J Pediatr Hematol Oncol; 2012 May; 34 Suppl 2():S37-8. PubMed ID: 22525404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational genomics for rare cancers: Challenges and opportunity.
    Tan AC; Huang PH
    Semin Cancer Biol; 2020 Apr; 61():iii-iv. PubMed ID: 32092353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.